Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 92-0342022 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To accelerate the discovery of treatment and cures for wolfram syndrome and eventually other rare and ultra-rare diseases.
Total Revenue
$157K
FY2024
Total Expenses
$71K
FY2024
Net Assets
$314K
Program Ratio
40.3%
expenses on programs
Employees
0
Volunteers
—
Board Members
3
Voting
3
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.